← All stories
Markets
Oxford Nanopore (LSE:ONT): How Far Does the Rare Disease Partnership Reach?
Highlights An agreement will incorporate the group's sequencing technology into a rare disease diagnostic platform. A chief medical officer has joined, with a chief marketing and communications officer following. Management continues to tar…
Covered by 1 outlet
All coverage · 1 article